Back to search
Schizophrenia and Schizoaffective Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia and Schizoaffective Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Schizophrenia and Schizoaffective Disorder trials you may qualify forThis study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMA…
The current study is an open-label, proof-of-concept, pilot trial examining the feasibility, safety, and preliminary efficacy of a 6-week group therapy interven…
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-…
Several observations have been made with magnetic resonance imaging (MRI) that characterize brain connections and brain function in individuals with schizophren…
Individuals living with a psychotic disorder often experience changes to their thinking and social skills that can lead to challenges with work, school, relatio…
This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.
This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function t…
The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer n…
The purpose of this study is to understand the biologic basis of schizophrenia and to determine which symptoms are related to the illness itself and which are r…